Insmed Inc (NASDAQ:INSM)’s traded shares stood at 7.16 million during the last session, with the company’s beta value hitting 0.81. At the close of trading, the stock’s price was $96.88, to imply a decrease of -1.12% or -$1.1 in intraday trading. The INSM share’s 52-week high remains $98.95, putting it -2.14% down since that peak but still an impressive 37.65% since price per share fell to its 52-week low of $60.40. The company has a valuation of $17.65B, with an average of 5.23 million shares in intraday trading volume over the past 10 days and average of 2.67 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Insmed Inc (INSM), translating to a mean rating of 1.06. Of 14 analyst(s) looking at the stock, 1 analyst(s) give INSM a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 13 recommend it as a Buy.
Insmed Inc (NASDAQ:INSM) trade information
After registering a -1.12% downside in the last session, Insmed Inc (INSM) has traded red over the past five days. The 5-day price performance for the stock is 33.19%, and 47.44% over 30 days. With these gigs, the year-to-date price performance is 40.32%. Short interest in Insmed Inc (NASDAQ:INSM) saw shorts transact 17.46 million shares and set a 7.75 days time to cover.
The extremes give us $110 and $110 for target low and target high price respectively. As such, INSM has been trading -13.54% off suggested target high and -13.54% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -13.12% for the past 5-year period. While 2025 is set for a 6.47% return in earnings, projections for the next 5 years are at 47.55% annually.
INSM Dividends
Insmed Inc has its next earnings report out on 2025-May-07. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Insmed Inc (NASDAQ:INSM)’s Major holders
Insmed Inc insiders hold 0.81% of total outstanding shares, with institutional holders owning 115.69% of the shares at 116.63% float percentage. In total, 115.69% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 16.01 million shares (or 10.3509% of shares), all amounting to roughly $1.07 billion.
The next major institution holding the largest number of shares is BLACKROCK INC. with 14.26 million shares, or about 9.2206% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $955.72 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and T. Rowe Price New Horizons Fund, Inc. as the top two Mutual Funds with the largest holdings of the Insmed Inc (INSM) shares. Going by data provided on Mar 31, 2025 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 5.73 shares. This is just over 3.14% of the total shares, with a market valuation of $554.93 million. Data from the same date shows that the other fund manager holds a little less at 4.61, or 2.53% of the shares, all valued at about 446.85 million.
